Raymond James & Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.11B | Buy |
6,864,404
+596,984
| +10% | +$95.1M | 0.68% | 22 |
|
|
2024
Q2 | $916M | Sell |
6,267,420
-116,921
| -2% | -$17.4M | 0.6% | 26 |
|
|
2024
Q1 | $1.01B | Buy |
6,384,341
+322,634
| +5% | +$51.4M | 0.68% | 21 |
|
|
2023
Q4 | $950M | Buy |
6,061,707
+26,982
| +0.4% | +$4.14M | 0.71% | 18 |
|
|
2023
Q3 | $940M | Sell |
6,034,725
-187,448
| -3% | -$30.9M | 0.79% | 15 |
|
|
2023
Q2 | $1.03B | Buy |
6,222,173
+132,557
| +2% | +$21.4M | 0.85% | 14 |
|
|
2023
Q1 | $944M | Buy |
6,089,616
+261,975
| +4% | +$42.3M | 0.82% | 13 |
|
|
2022
Q4 | $1.03B | Buy |
5,827,641
+359,785
| +7% | +$62.1M | 0.95% | 11 |
|
|
2022
Q3 | $893M | Buy |
5,467,856
+107,613
| +2% | +$18.2M | 0.9% | 11 |
|
|
2022
Q2 | $952M | Buy |
5,360,243
+106,194
| +2% | +$18.9M | 0.93% | 9 |
|
|
2022
Q1 | $931M | Buy |
5,254,049
+35,642
| +0.7% | +$6.06M | 0.79% | 14 |
|
|
2021
Q4 | $893M | Buy |
5,218,407
+118,759
| +2% | +$19.4M | 0.72% | 15 |
|
|
2021
Q3 | $824M | Sell |
5,099,648
-162,116
| -3% | -$27.7M | 0.74% | 12 |
|
|
2021
Q2 | $867M | Buy |
5,261,764
+1,477,064
| +39% | +$245M | 0.79% | 13 |
|
|
2021
Q1 | $622M | Sell |
3,784,700
-68,689
| -2% | -$11.1M | 0.63% | 19 |
|
|
2020
Q4 | $606M | Buy |
3,853,389
+165,219
| +4% | +$24.4M | 0.67% | 23 |
|
|
2020
Q3 | $549M | Buy |
3,688,170
+17,275
| +0.5% | +$2.56M | 0.69% | 20 |
|
|
2020
Q2 | $516M | Buy |
3,670,895
+128,618
| +4% | +$18.7M | 0.69% | 22 |
|
|
2020
Q1 | $465M | Buy |
3,542,277
+32,908
| +0.9% | +$4.67M | 0.74% | 19 |
|
|
2019
Q4 | $512M | Buy |
3,509,369
+288,665
| +9% | +$39.2M | 0.65% | 24 |
|
|
2019
Q3 | $417M | Sell |
3,220,704
-147,789
| -4% | -$19.5M | 0.58% | 25 |
|
|
2019
Q2 | $469M | Buy |
3,368,493
+33,985
| +1% | +$4.7M | 0.68% | 20 |
|
|
2019
Q1 | $466M | Sell |
3,334,508
-207,640
| -6% | -$27.8M | 0.71% | 17 |
|
|
2018
Q4 | $457M | Buy |
3,542,148
+102,193
| +3% | +$14.3M | 0.8% | 15 |
|
|
2018
Q3 | $475M | Buy |
3,439,955
+166,366
| +5% | +$22.1M | 0.73% | 16 |
|
|
2018
Q2 | $397M | Buy |
3,273,589
+181,560
| +6% | +$22.7M | 0.67% | 18 |
|
|
2018
Q1 | $396M | Buy |
3,092,029
+244,662
| +9% | +$33.1M | 0.71% | 18 |
|
|
2017
Q4 | $398M | Buy |
2,847,367
+131,429
| +5% | +$18.3M | 0.73% | 14 |
|
|
2017
Q3 | $353M | Buy |
2,715,938
+72,286
| +3% | +$9.58M | 0.71% | 16 |
|
|
2017
Q2 | $350M | Buy |
2,643,652
+65,952
| +3% | +$8.41M | 0.76% | 13 |
|
|
2017
Q1 | $321M | Sell |
2,577,700
-180,589
| -7% | -$21.6M | 0.75% | 13 |
|
|
2016
Q4 | $318M | Sell |
2,758,289
-66,829
| -2% | -$7.72M | 0.81% | 15 |
|
|
2016
Q3 | $334M | Buy |
2,825,118
+145,712
| +5% | +$17.7M | 0.91% | 11 |
|
|
2016
Q2 | $325M | Buy |
2,679,406
+203,618
| +8% | +$23.1M | 1.02% | 11 |
|
|
2016
Q1 | $268M | Buy |
2,475,788
+247,537
| +11% | +$25.6M | 0.91% | 11 |
|
|
2015
Q4 | $229M | Buy |
2,228,251
+53,006
| +2% | +$5.33M | 0.82% | 11 |
|
|
2015
Q3 | $203M | Buy |
2,175,245
+468,030
| +27% | +$45.3M | 0.83% | 10 |
|
|
2015
Q2 | $166M | Buy |
1,707,215
+61,356
| +4% | +$6.14M | 0.64% | 17 |
|
|
2015
Q1 | $166M | Buy |
1,645,859
+177,952
| +12% | +$18.1M | 0.73% | 13 |
|
|
2014
Q4 | $153M | Buy |
1,467,907
+47,359
| +3% | +$4.99M | 0.75% | 15 |
|
|
2014
Q3 | $151M | Buy |
1,420,548
+232,356
| +20% | +$24.1M | 0.87% | 10 |
|
|
2014
Q2 | $124M | Buy |
1,188,192
+13,383
| +1% | +$1.35M | 0.77% | 10 |
|
|
2014
Q1 | $115M | Buy |
1,174,809
+87,479
| +8% | +$8.11M | 0.79% | 10 |
|
|
2013
Q4 | $99.6M | Sell |
1,087,330
-34,244
| -3% | -$3.16M | 0.75% | 10 |
|
|
2013
Q3 | $97.2M | Sell |
1,121,574
-82,552
| -7% | -$7.41M | 0.84% | 8 |
|
|
2013
Q2 | $103M | Buy |
+1,204,126
| New | +$102M | 0.98% | 8 |
|
Other funds holding JNJ
Raymond James & Associates's JNJ Position: Q3 2024 in Review
Raymond James & Associates increased its Johnson & Johnson (JNJ) stake by 9.5% in Q3 2024, buying an estimated $95.1M and bringing the position to 6,864,404 shares worth $1.11B. The position accounts for 0.68% of the portfolio, ranked #22.
Raymond James & Associates first reported a position in JNJ in Q2 2013 and has held it in 46 quarters since. 3,881 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.
- Raymond James & Associates held 6,864,404 shares of Johnson & Johnson worth $1.11B as of Q3 2024.
- Raymond James & Associates bought 596,984 Johnson & Johnson shares in Q3 2024, an estimated $95.1M.
- Johnson & Johnson made up 0.68% of Raymond James & Associates's portfolio in Q3 2024, its #22 holding.
- Raymond James & Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 46 quarters since.
- 3,881 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.